皮肤组织工程支架材料

皮肤组织工程支架材料为种子细胞提供生长和代谢的环境,是人工皮肤研究中的重要内容,可按来源分为合成支架材料和天然支架材料。近几年的研究重点是:前者通过表面仿生技术增强其对细胞的黏附性;后者通过物理或化学方法提高其力学性能和渗透性等。今后应重点研究以下内容:深入研究合成支架材料的表面改性,进一步提高其引导细胞行为的功能,促进材料对细胞的黏附;进一步提高天然支架材料的微观渗透性和生物活性,促进毛细血管的长入;制备结构仿生支架材料及高活性复合支架材料。     

基于组织工程研究的可降解支架材料选择策略

目前,器官或组织移植是治疗器官衰竭或大范围组织缺损唯一长期有效的方法,但存在供体短缺、免疫排斥等问题。组织工程技术作为一种潜在的替代治疗方法,支架材料的选择是其中具有决定意义的组成部分。组织工程支架材料按其来源可分为天然及其改性修饰材料、人工合成与复合支架材料3种。组织工程目的就是修复临床上的病损组织或器官,并达到较理想的结构和功能的恢复。因此组织工程支架也必须从基本性质上具有一定的仿生化结构及功能,即"活"支架,这样才能彻底代替病损组织或器官。通过多种支架材料的优化组合(即材料的复合),对材料进行表面改性、制备工艺优化及添加细胞因子缓释微球等技术,模拟病损器官组织的特性及周围环境,有望打开组织工程的新局面。理想的组织工程支架应当以临床需要为根本目的,依靠材料学、分子生物学、工程学等多学科间的交叉研究,取各家之长,优化配比组合,达到仿生的目的。本课题组前期工作已经将骨髓间充质干细胞体外诱导分化为胆管上皮样细胞,并设计出左旋聚乳酸/聚己内酯共聚物(PLCL)胆道支架,内部混有包含生长因子的纳米缓释微球,供细胞因子的远期释放,支架内表面涂有基质胶/胶原混合层,且胶内加入bFGF、EGF,提供诱导因子的早期释放。将诱导细胞与PLCL胆道支架复合,制备组织工程胆管。文中综述了现存各类支架材料的研究状况,简单介绍了制备工艺、表面修饰等影响支架性能的因素,力求探索组织工程支架材料的选择策略。     

仿生聚己内酯支架用于乳房组织工程的可行性研究

目的探讨聚己内酯（PCL）乳房形态支架用于组织工程乳房的构建的可能性。 方法通过熔融沉积3D打印制备形态仿生的PCL支架,测量其机械性能,并使用新西兰大白兔动物模型,皮下植入该PCL支架12周和18周后,利用核磁共振成像（MRI）观察支架内部新生组织分布情况,在组织学（HE、Masson及EVG染色）上评估支架内部的脂肪、纤维及血管的分布情况,并进一步使用qRT-PCR检测了12周时PCL支架内部组织的成脂相关基因（PPAR-γ、C/EBP-β、AP-2）、炎症相关基因TNF-α及巨噬细胞标记物F4-80的表达情况,同时使用凝胶渗透色谱法分析了PCL植入体内后平均分子量的变化。2组间均数比较采用独立样本t检验,多组间比较采用单因素方差分析,组间两两比较采用LSD-t检验,配对设计的均数比较采用配对t检验。 结果制备的PCL支架孔隙率为（85.30±1.12）%,压缩模量为（8.18±1.39）MPa,植入新西兰大白兔动物模型皮下12周后,MRI影像学显示脂肪组织已由支架周围向内部侵入,HE、Masson及EVG染色同样在该支架边缘观察到部分新生脂肪组织及血管,而支架内部则以疏松排列的纤维组织为主;与原生脂肪比较,12周PCL支架内组织的基因表达分析成脂相关基因C/EBPβ表达水平（2.32±0.28比1.00±0.02）升高,而巨噬细胞标记物F4/80表达（0.80±0.12比1.00±0.03）降低（P均< 0.01）;18周后,HE染色证实支架内部已充满脂肪组织。基因表达证实,与原生脂肪比较,支架内部组织C/EBP-β （3.30±0.63比1.00±0.02）,PPAR-γ （1.81±0.71比0.99±0.02）及AP-2表达水平（1.38±0.16比1.01±0.01）升高（P均< 0.01）;而TNF-α（0.50±0.15比1.00±0.01）及F4/80表达水平（0.52±0.09比1.00±0.03）均降低（P均< 0.001）。而植入体内PCL支架的分子量（M_n）在18周内变化不大[（65.04±2.24）kDa比（64.20±4.09） kDa]。 结论PCL支架具有较好的生物相容性,可用于组织工程乳房的构建,该新西兰大白兔动物模型的建立有利于乳房组织工程的进一步临床转化。     

肌腱组织工程支架与种子细胞研究进展

目的:综述肌腱组织工程支架材料、细胞来源、制备技术及体外构建的研究进展.方法:查阅近期肌腱组织工程研究的相关文献,对组织工程肌腱支架的材料来源、制备技术,复合细胞种类,体外构建力学刺激等进行分析、归纳.结果:肌腱组织工程支架材料有天然材料、人工合成材料及复合材料等;制备技术包括静电纺丝和编织法等;其中支架材料的表面修饰是组织工程化肌腱构建的重要环节.与肌腱材料进行复合的种子细胞有肌腱细胞、骨髓间充质干细胞及成纤维细胞等.结论:复合材料是近年肌腱组织工程支架材料研究的重点,静电纺丝技术是一种具有潜力的支架制备技术,支架材料的表面修饰可促进细胞在支架上的黏附及肌腱的形成,种子细胞的研究仍是肌腱组织工程发展的瓶颈,周期性张力的存在为组织工程化肌腱的形成创造了条件.     

组织工程静脉血管种子细胞的培养

目的获取可应用于静脉血管组织工程的种子细胞内皮细胞。方法选取北京地区雄性杂种犬,取其双侧颈外静脉,采用翻转后酶消法,获取原代内皮细胞,对其进行原代培养和传代培养,冻存、复苏和鉴定,并利用光学显微镜进行观察。结果获取犬的颈外静脉后,实验采取了翻转后酶消法,所获得的内皮细胞纯度和数量得到了提高;经过鉴定确实为内皮细胞来源;活性好,增殖快,在较短的时间内能够达到后期实验所需数量。结论经体外培养的犬的颈外静脉内皮细胞可以作为组织工程血管的种子细胞。     

生物支架材料——组织工程连载之二

具有三维结构的支架材料是组织工程的核心内容之一。现有组织工程支架可分为天然生物材料、合成有机材料和无机材料三类。支架材料近年来研究十分活跃,不仅在组织工程的最早产品人工皮肤领域进行了更为完善的研究和开发,同时在诸如人工骨、软骨、神经、血管、皮肤、肝、脾、肾、膀胱等方面进行了大量研究和探索。与普通组织工程支架需要预先制备并在体外成型不同,近年来在骨和软骨组织工程实践中兴起的可注射支架具有许多优势,是未来组织工程支架发展的重要方向之一。     

全生物化组织工程血管SMA、PDGF-AA及MMP-2的表达

目的探讨血管平滑肌细胞的α-actin(SMA)、血小板源性生长因子-AA(PDGF-AA)及金属蛋白酶-2(MMP-2)的表达情况。方法采用以酶消化为主的方法制备猪颈总动脉脱细胞支架,再种植犬胸主动脉的平滑肌细胞,培养4周,分别于2周和4周取材作形态学观察和SMA、MMP-2及PDGF-AA的免疫组化染色及图象分析,并以幼年犬和成年犬的胸主动脉作对照。结果组织工程血管培养2周和4周,α-actin的表达高于幼年犬,但明显低于成年犬;PDGF-AA表达低于幼年犬,但明显高于成年犬;MMP-2高于成年犬,培养4周时MMP-2的表达接近幼年犬。结论全生物化组织工程血管体外构建中VSMC的PDGF-AA和ECM的表达逐渐增多,SMA的表达逐渐减少,VSMC由收缩表型逐渐转变为合成表型,VSMC大量增殖,伴有新的细胞外基质产生,同时MMP-2分泌增加,促进种植细胞的迁移,重建了组织工程血管的管壁结构。     

Evidence for extracellular localization of activator calcium in dog coronary artery smooth muscle as studied by the pyroantimonate method

Summary Correlated physiological and electron-microscopic studies were made on the source of calcium activating the contractile system (activator calcium) in dog coronary artery smooth muscle fibers. The magnitude of contracture tension induced by 100 mM K⁺ was dependent on external Ca²⁺ concentration and reduced or eliminated by factors known to reduce the Ca²⁺ spike or ca²⁺ influx. Little or no mechanical response was elicited by treatments known to cause release of intracellularly stored calcium. These results indicated that the contractile system is mainly activated by the inward movement of extracellular calcium. In accordance with the physiological experiments, electron-opaque pyroantimonate precipitate containing calcium was found in the lumina of caveolae, but not in any intracellular structures close to the plasma membrane, when the relaxed fibers were fixed in a 1% osmium tetroxide solution containing 2% potassium pyroantimonate. If the contracted fibers were fixed in the same solution, the pyroantimonate precipitate was diffusely distributed in the myoplasm in the form of numerous particles, while the precipitate in the caveolar lumina was scarcely seen. These findings are discussed in connection with the regulation of intracellular Ca²⁺ concentration in dog coronary artery smooth muscle.     

Efficient generation of smooth muscle cells from adipose‐derived stromal cells by 3D mechanical stimulation can substitute the use of growth factors in vascular tissue engineering

Occluding artery disease causes a high demand for bioartificial replacement vessels. We investigated the combined use of biodegradable and creep‐free poly (1,3‐trimethylene carbonate) (PTMC) with smooth muscle cells (SMC) derived by biochemical or mechanical stimulation of adipose tissue‐derived stromal cells (ASC) to engineer bioartificial arteries. Biochemical induction of cultured ASC to SMC was done with TGF‐β1 for 7d. Phenotype and function were assessed by qRT‐PCR, immunodetection and collagen contraction assays. The influence of mechanical stimulation on non‐differentiated and pre‐differentiated ASC, loaded in porous tubular PTMC scaffolds, was assessed after culturing under pulsatile flow for 14d. Assays included qRT‐PCR, production of extracellular matrix and scanning electron microscopy. ASC adhesion and TGF‐β1‐driven differentiation to contractile SMC on PTMC did not differ from tissue culture polystyrene controls. Mesenchymal and SMC markers were increased compared to controls. Interestingly, pre‐differentiated ASC had only marginal higher contractility than controls. Moreover, in 3D PTMC scaffolds, mechanical stimulation yielded well‐aligned ASC‐derived SMC which deposited ECM. Under the same conditions, pre‐differentiated ASC‐derived SMC maintained their SMC phenotype. Our results show that mechanical stimulation can replace TGF‐β1 pre‐stimulation to generate SMC from ASC and that pre‐differentiated ASC keep their SMC phenotype with increased expression of SMC markers.     

Evolution of covered stents in the contemporary era: clinical application,materials and manufacturing strategies using nanotechnology

Endovascular stents have revolutionised the field of interventional cardiology. Despite their excellent clinical outcome complications associated with percutaneous stent implantation following the procedure have remained a major drawback in their widespread use. To overcome such limitations, a number of novel endovascular stents have emerged including a covered stent wrapped in a thin membrane sleeve. As well as prevention of complications associated with stenting, covered stents owing to their physical barrier are used as the treatment option of choice for trauma devices during emergency situations and to treat a number of pathological disease states. The aim of this review is to provide the reader with an overall objective outlook in the use of covered stents as a treatment option in a number of vascular complications and addresses their design and materials used in the manufacturing process. In addition, new strategies are highlighted and future prospects with the emergence of novel smart alloys for 3D scaffolds and the use of nanotechnology in the development of nanocomposite materials.